Sana Biotechnology Inc [SANA] stock is trading at $3.96, down -0.25%. An important factor to consider is whether the stock is rising or falling in short-term value. The SANA shares have gain 18.56% over the last week, with a monthly amount glided 32.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on September 24, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $5. On March 18, 2025, upgrade upgraded it’s rating to Mkt Outperform but maintained its price target of $5 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $7 on March 14, 2025. TD Cowen upgraded its rating to a Buy. JMP Securities downgraded its rating to Mkt Perform for this stock on November 05, 2024. In a note dated June 26, 2024, Rodman & Renshaw initiated an Buy rating and provided a target price of $16 on this stock.
Sana Biotechnology Inc [SANA] stock has fluctuated between $1.26 and $7.30 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $3.96 at the most recent close of the market. An investor can expect a potential return of 102.02% based on the average SANA price forecast.
Analyzing the SANA fundamentals
Gross Profit Margin for this corporation currently stands at -0.19% with Operating Profit Margin at -16.9%, Pretax Profit Margin comes in at -16.5%, and Net Profit Margin reading is -16.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -1.15 and Total Capital is -0.79. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.85 points at the first support level, and at 3.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.09, and for the 2nd resistance point, it is at 4.23.
Ratios To Look Out For
For context, Sana Biotechnology Inc’s Current Ratio is 2.47. On the other hand, the Quick Ratio is 2.47, and the Cash Ratio is 2.13.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares. Meanwhile, FMR LLC sold 0.29 million shares on Jan 08 ’25.
